CKLF与IL1B转录水平可预测儿童前B细胞急性淋巴细胞白血病复发
该研究旨在解决儿童B-ALL复发风险分层不足的问题,采用机器学习方法识别与不良生存相关的白血病原始细胞分泌因子。研究识别出一个双基因表达特征(CKLF和IL1B),可在诊断时识别高危患者,并增强现有诊断时或诱导结束风险分层的预测价值,提示该模型可连续应用以指导风险 adapted 治疗。
要点
- CKLF和IL1B双基因表达特征可在诊断时识别高危B-ALL患者。
- 该特征增强现有诊断时或诱导结束风险分层的预测价值。
- 模型可连续应用以指导风险 adapted 治疗的实施。
核心结论
- CKLF和IL1B转录水平在诊断时可预测儿童前B细胞急性淋巴细胞白血病复发。
研究设计与样本
- 使用机器学习方法识别B-ALL原始细胞分泌的与不良生存结局相关的因子。
主要发现
- 识别出一个双基因表达特征(CKLF和IL1B),可在诊断时识别高危患者。
- 该双基因表达特征增强了当前诊断时或诱导结束风险分层的预测价值。
临床怎么用
- 该模型可连续应用以帮助指导风险 adapted 治疗的实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Disease relapse is the greatest cause of treatment failure in paediatric B-cell acute lymphoblastic leukaemia (B-ALL). Current risk stratifications fail to capture all patients at risk of relapse. Herein, we used a machine-learning approach to identify B-ALL blast-secreted factors that are associated with poor survival outcomes. Using this approach, we identified a two-gene expression signature (CKLF and IL1B) that allowed identification of high-risk patients at diagnosis. This two-gene expression signature enhances the predictive value of current at diagnosis or end-of-induction risk stratification suggesting the model can be applied continuously to help guide implementation of risk-adapted therapies.
引用
- Fitter S, Bradey AL, Kok CH, et al. CKLF and IL1B transcript levels at diagnosis are predictive of relapse in children with pre-B-cell acute lymphoblastic leukaemia. Br J Haematol. 2021. PMID: 33620089. doi:10.1111/bjh.17161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。